Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty: Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) registry and the Myocardial Infarction Registry (MIR)

Herz

Volumn 25, Issue 7, 2000, Pages 667-675

  Zahn, Ralf ^a   Schiele, Rudolf ^a   Schneider, Steffen ^a   Gitt, Anselm Kai ^a   Heer, Thomas ^a   Wienbergen, Harm ^a   Gottwik, Martin ^b   Altmann, Ernst ^c   Grube, Rolf ^d   Becker, Gregor ^e   Baumgärtel, Bernd ^f   Senges, Jochen ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b KLINIKUM NÜRNBERG   (Germany)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^d Neurologische Klinik Kreiskrankenhaus Freiberg gGmbH   (Germany)

^e Stadtisches Krankenhaus Kiel   (Germany)

^f Kreiskrankenhaus Freital   (Germany)

Author keywords

Acute myocardial infarction; Clinical practice; Primary angioplasty; Reperfusion therapy

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CLINICAL PRACTICE; CORONARY ARTERY DILATATION; FIBRINOLYTIC THERAPY; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATIENT TRANSPORT;

EID: 0033748124     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00001981     Document Type: Article

References (34)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
4. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
5. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy
6. PTCA for acute myocardial infarction in patients not eligible for iv thrombolysis: In-hospital results
7. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial
8. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy
9. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2)
10. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock
11. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction
12. Primary angioplasty in a community hospital in the USA
13. Immediate angioplasty in the United Kingdom
14. Acute myocardial infarction: Pre-hospital and in-hospital management
15. Richtlinien der interventionellen koronartherapie
16. ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
17. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
18. Early treatment of acute myocardial infarct: Implementation of therapy guidelines in routine clinical practice, MITRA pilot phase
19. Acute myocardial infarction in Germany between 1996 and 1998: Therapy and intrahospital course. Results of the myocardial infarction registry (MIR) in Germany
20. Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty
21. Predictors of death and reinfarction at 30 days after primary angioplasty: The GUSTO IIb and RAPPORT trials
22. Lessons from the pooled outcome of the PAMI, Zwolle and the Mayo Clinic randomized trials of primary angioplasty versus thrombolytic therapy of acute myocardial infarction
23. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: Report of an initial experience
24. Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction
25. Helicopter transport of patients during acute myocardial infarction
26. Hospital transfer for primary coronary angioplasty in high risk patients with acute myocardial infarction
27. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study
28. Early referral for intentional rescue PTCA after initiation of thrombolytic therapy in patients admitted to a community hospital because of a large acute myocardial infarction
29. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: A safety and feasibility study
30. The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial
31. What is the optimal treatment for thrombolytic ineligible AMI? Preliminary results of the study of medicine vs angioplasty reperfusion trial (SMART)
32. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction
33. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: Results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial
34. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty